.. Limites-de-l-'étude, 40 1.1. Points faibles, p.40

N. Bajos, M. Rouzaud-cornabas, H. Panjo, A. Bohet, and C. Moreau, La crise de la pilule en France : vers un nouveau modèle contraceptif ?, pp.1-4

N. Bajos, A. Bohet, L. Guen, M. Moreau, and C. , La contraception en France : nouveau contexte, nouvelles pratiques ? Popul Soc, pp.1-4, 2012.

D. Serfaty, Le marché de la contraception en France en 2015 : la pilule estroprogestative a poursuivi sa dépression, Journal Faxé du Gynécologue

A. Gautier, D. Kersaudy-rahib, and N. Lydié, Pratiques contraceptives des jeunes femmes de moins de 30 ans, Analyse du baromètre santé 2010. INPES, pp.145-54
DOI : 10.3917/agora.063.0088

H. Autorité and D. Santé, Contraception chez la femme adulte en âge de procréer, hors post-partum et post-IVG [en ligne] http://www.has-sante.fr/portail/jcms/c_1752542/fr/contraception-chez-la-femme-adulte-en- age-de-procreer-hors-post-partum-et-post-ivg?xtmc=&xtcr=2#toc_2_3, 2004.

A. Vilain and M. Mouquet, Les interruptions volontaires de grossesse en 2013, Etudes Résultats. DREES. Juil, issue.924, pp.1-6, 2015.

H. Autorité and D. Santé, Méthodes contraceptives : Focus sur les méthodes les plus efficaces disponibles, p.15, 2013.

N. Bajos, C. Moreau, H. Leridon, and M. Ferrand, Pourquoi le nombre d'IVG n'a-t-il pas baissé en France depuis 30 ans ? Popul Soc, pp.1-4, 2004.

N. Bajos, H. Leridon, H. Goulard, P. Oustry, N. Job-spira et al., Contraception: from accessibilty to efficiency. Human Reprod, pp.994-1003, 2003.

W. Rinehart, R. S. Drennan, and M. , GATHER guide to counseling, Popul Rep J, vol.4810, pp.1-31, 1998.

B. Rondot-mattauer, Interruption volontaire de grossesse : la dynamique du sens. Paris : Erès, 2003.

C. Aubin, D. Jourdain-menniger, and L. Chambaud, la prévention des grossesses non désirées : contraception et contraception d'urgence. Rapport IGAS, 2009.

T. Behringer, M. Reeves, B. Rossiter, B. Chen, and E. Schwarz, Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women. Contraception, pp.5-10, 2011.

J. Friedman, Factors Associated with Contraceptive Satisfaction in Adolescent Women Using the IUD, Journal of Pediatric and Adolescent Gynecology, vol.28, issue.1, pp.38-42
DOI : 10.1016/j.jpag.2014.02.015

S. Prager and P. Darney, The levonorgestrel intrauterine system in nulliparous women. Contraception, pp.12-15, 2007.

A. Berenson, A. Tan, J. Hirth, and G. Wilkinson, Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers, Obstetrics & Gynecology, vol.121, issue.5, pp.951-959, 2013.
DOI : 10.1097/AOG.0b013e31828b63a0

M. Tuppurainen, E. Lukkari-lax, J. Grunert, and S. Rybowski, A 12-month multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with the etonogestrel subdermal contraceptive implant in women aged 18???35 years, Fertility and Sterility, vol.102, issue.3, pp.18-35
DOI : 10.1016/j.fertnstert.2014.07.486

L. Borgatta, K. Roth, S. Rybowski, and K. Rosen, A multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with a combined oral contraceptive: analysis of user satisfaction and safety, Fertility and Sterility, vol.102, issue.3, p.12, 2014.
DOI : 10.1016/j.fertnstert.2014.07.048

J. Peipert, Q. Zhao, J. Allsworth, E. Petrosky, T. Madden et al., Continuation and Satisfaction of Reversible Contraception, Obstetrics & Gynecology, vol.117, issue.5, pp.1105-1118, 2011.
DOI : 10.1097/AOG.0b013e31821188ad

H. Autorité and D. Santé, Etat des lieux des pratiques contraceptives et des freins à l'accès et au choix d'une contraception adaptée, 2013.

C. Tyler, M. Whiteman, L. Zapata, K. Curtis, S. Hillis et al., Health Care Provider Attitudes and Practices Related to Intrauterine Devices for Nulliparous Women, Obstetrics & Gynecology, vol.119, issue.4
DOI : 10.1097/AOG.0b013e31824aca39

E. Stubbs and A. Schamp, The evidence is in. Why are IUDs still out ? Family physicians perceptions of risk and indications. Can Fam Physician, pp.560-566, 2008.

E. Smith, M. Daley, and A. , A clinical guideline for intrauterine device use in adolescents, Journal of the American Academy of Nurse Practitioners, vol.46, issue.7, pp.453-62
DOI : 10.1111/j.1745-7599.2012.00753.x

G. Secura, J. Allsworth, T. Madden, J. Mullersman, and J. Peipert, The contraceptive CHOICE Project : reducting barriers to longactive reversible contraception, Am J Obstet Gynecol, vol.203, issue.2, pp.115-122, 2010.

K. Fleming, A. Sokoloff, and T. Raine, Attitudes and beliefs about the intrauterine device among teenagers and young women. Contraception, pp.178-82, 2010.

D. Dorothée, Freins et réticences à l'utilisation du dispositif intra-utérin chez les nullipares en médecine générale. Thèse d'exercice : Médecine générale : Versailles -Saint Quentin en Yvelines, 2012.

D. Serfaty, Contraception. 4 ème édition. Issy-les-Moulineaux, 2011.

O. Mondiale-de and L. Santé, Critères de recevabilité pour l'adoption et l'utilisation continue des méthodes contraceptives. 4 ème édition, 2009.

I. Navarria, O. Julen, F. Narring, and M. Yaron, Un nouveau regard sur la contraception des adolescentes: pourquoi prescrire un dispositif intra-utérin en première intention ?, Rev Med Suisse, vol.11, pp.78-81, 2015.

D. Hubacher, S. Lillo, A. Zepeda, P. Chen, and H. Croxatto, Pain from copper intrauterine device insertion: Randomized trial of prophylactic ibuprofen, American Journal of Obstetrics and Gynecology, vol.195, issue.5, pp.1272-1279, 2006.
DOI : 10.1016/j.ajog.2006.08.022

K. Gemzell-danielsson, I. Schellschmidt, and D. Apter, A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena, Fertility and Sterility, vol.97, issue.3, pp.616-638, 2012.
DOI : 10.1016/j.fertnstert.2011.12.003

A. Nelson, K. Danielsson, L. Borgotta, B. Hauck, R. Lynen et al., User satisfaction, ease of placement, and discomfort during placement of two low-dose levonorgestrel contraceptive intrauterine systems (LNG-IUS) in a multicenter, randomized, phase 3 study, Fertility and Sterility, vol.98, issue.3, p.194, 2012.
DOI : 10.1016/j.fertnstert.2012.07.711

S. Lori, Méthode de pose directe des dispositifs intra-utérin : comment ? Pourquoi ? Mémoire : DIU Régulation des naissances : Paris Descartes, 2015.

A. Dermish, D. Turok, J. Jacobson, K. Burke, and M. Flores, Failed IUD insertions in nulliparous and parous women. Contraception, Sept, vol.84, issue.3, p.332, 2011.

M. Farmer and A. Webb, Intrauterine device insertion-related complications : can they be predicted ? J Fam Plann Reprod Health Care, pp.227-258, 2003.

T. Faustmann, D. Apter, E. Lukkari-lax, G. Montegriffo, and . Danielsson, A 12-month, Phase III study of a low-dose levonorgestrel intrauterine contraceptive system (LNG-IUS13.5mg) in postmenarcheal adolescents: an evaluation of placement ease and pain, bleeding and dysmenorrhea, Fertility and Sterility, vol.104, issue.3, p.39, 2015.
DOI : 10.1016/j.fertnstert.2015.07.120

R. Lyus, P. Lohr, and S. Prager, Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. Contraception, pp.367-71, 2010.

M. Boudineau, O. Multon, and P. Lopes, Contraception par dispositif intra-ut??rin, EMC - Gyn??cologie, vol.1, issue.1
DOI : 10.1016/S0246-1064(01)00051-2

D. Hubacher, Copper intrauterine device use by nulliparous women: review of side effects, Contraception, vol.75, issue.6, pp.8-11, 2007.
DOI : 10.1016/j.contraception.2006.12.005

A. Nelson, K. Gemzell-danielsson, S. Drosman, R. Lynen, and K. Rosen, A multicenter, randomized, phase 3 study of two low-dose levonorgestrel contraceptive intrauterine systems (LNG-IUS): a subgroup analysis in nulliparous women, Fertility and Sterility, vol.98, issue.3, p.196, 2012.
DOI : 10.1016/j.fertnstert.2012.07.717

T. Backman, I. Rauramo, S. Huhtala, and M. Koskenvuo, Pregnancy during the use of levonorgestrel intrauterine system, American Journal of Obstetrics and Gynecology, vol.190, issue.1, pp.50-54, 2004.
DOI : 10.1016/j.ajog.2003.07.021

S. Carr and E. Espey, Intrauterine Devices and Pelvic Inflammatory Disease Among Adolescents, Journal of Adolescent Health, vol.52, issue.4, pp.22-30
DOI : 10.1016/j.jadohealth.2013.01.017

P. Hillard, Practical Tips for Intrauterine Devices Use in Adolescents, Journal of Adolescent Health, vol.52, issue.4, pp.40-46
DOI : 10.1016/j.jadohealth.2012.09.023

K. Workowski and S. Berman, CDC Sexually Transmitted Diseases Treatment Guidelines, Clinical Infectious Diseases, vol.35, issue.s2, 2010.
DOI : 10.1086/342100

J. Toivonen, T. Luukkainen, and H. Allonen, Protective Effect of Intrauterine Release of Levonorgestrel on Pelvic Infection: Three Years?? Comparative Experience of Levonorgestrel- and Copper-Releasing Intrauterine Devices, Obstetrics & Gynecology, vol.77, issue.2, pp.261-265, 1991.
DOI : 10.1097/00006250-199102000-00019

K. Andersson, V. Odlind, and G. Rybo, Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial, Contraception, vol.49, issue.1, pp.56-72, 1994.
DOI : 10.1016/0010-7824(94)90109-0

S. Koh and K. Singh, The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia, Journal of Thrombosis and Haemostasis, vol.86, issue.1, pp.133-141, 2007.
DOI : 10.1111/j.1538-7836.2006.02243.x

A. Anpalagan and G. Condous, Is There a Role for Use of Levonorgestrel Intrauterine System in Women with Chronic Pelvic Pain?, Journal of Minimally Invasive Gynecology, vol.15, issue.6, pp.663-669, 2008.
DOI : 10.1016/j.jmig.2008.07.008

J. Sheng, W. Zhang, J. Zhang, and D. Lu, The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis, Contraception, vol.79, issue.3, 2009.
DOI : 10.1016/j.contraception.2008.11.004

C. Ménard and A. Gautier, Inégalités et comportements de santé des 18-75 ans. Baromètre santé, INPES, vol.2, pp.391-420, 2000.

S. Manon, Echecs contraceptifs à l'origine d'une interruption volontaire de grossesse. Etude rétrospective portant sur 211

P. Sharma, C. Malhotra, D. Taneja, and R. Saha, Problems related to menstruation amongst adolescent girls, The Indian Journal of Pediatrics, vol.48, issue.2, pp.125-134, 2008.
DOI : 10.1007/s12098-008-0018-5

G. Marine and R. Aude, Place du dispositif intra-utérin dans l'arsenal contraceptif de la jeune femme nullipare en soins primaires. Thèse d'exercice : Médecine générale : Grenoble, 2013.

H. Thaïs, Peut-on poser un dispositif intra-utérin au cuivre chez une nullipare ?

P. Marion, Dispositif intra-utérin et nulliparité Représentations et évaluation des pratiques chez les gynécologues médicaux libéraux de la région Rhône-Alpes. Mémoire : Sage-femme : Lyon, 2014.

V. Goulet, B. De-barbeyrac, S. Raherison, M. Prudhomme, C. Semaille et al., Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France, Sexually Transmitted Infections, vol.86, issue.4, pp.263-70, 2010.
DOI : 10.1136/sti.2009.038752

URL : https://hal.archives-ouvertes.fr/hal-00557458

R. Allen, M. Carey, C. Raker, V. Goyal, and K. Matteson, A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries, Journal of Obstetrics and Gynaecology, vol.19, issue.3, pp.263-270
DOI : 10.1016/j.contraception.2003.11.008

W. Brown and K. Trouton, Intrauterine device insertions: which variables matter ? J Fam Plann Reprod Health Care, 2014, vol.40, issue.2, pp.117-138

E. Espey, R. Singh, L. Leeman, T. Ogburn, K. Fowler et al., Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial, American Journal of Obstetrics and Gynecology, vol.210, issue.3, pp.1-5, 2014.
DOI : 10.1016/j.ajog.2013.11.018

K. Dijkhuizen, O. Dekkers, C. Holleboom, C. De-groot, B. Hellebrekers et al., Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod, Feb, vol.26, issue.2, pp.323-332, 2011.

I. Sääv, A. Aronsson, L. Marions, O. Stephansson, and K. Gemzell-danielsson, Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial, Human Reproduction, vol.22, issue.10, pp.2647-52, 2007.
DOI : 10.1093/humrep/dem244

A. Brockmeyer, M. Kishen, and A. Webb, Experience of IUD/IUS insertions and clinical performance in nulliparous women???a pilot study, The European Journal of Contraception & Reproductive Health Care, vol.3, issue.3, 2008.
DOI : 10.1016/j.contraception.2006.12.005

M. Brown, C. Auerswald, S. Eyre, J. Deardorff, and C. Dehlendorf, Identifying Counseling Needs of Nulliparous Adolescent Intrauterine Contraceptive Users: A Qualitative Approach, Journal of Adolescent Health, vol.52, issue.3, pp.293-300, 2013.
DOI : 10.1016/j.jadohealth.2012.07.004

C. Harvey, D. Bateson, J. Wattimena, and K. Black, Ease of intrauterine contraceptive device insertion in family planning settings, Australian and New Zealand Journal of Obstetrics and Gynaecology, vol.57, issue.4, pp.534-543, 2012.
DOI : 10.1111/ajo.12007

M. Bahamondes, M. Hidalgo, L. Bahamondes, and I. Monteiro, Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas, Contraception, vol.84, issue.5, pp.11-17, 2011.
DOI : 10.1016/j.contraception.2011.05.012

K. Gemzell-danielsson, K. Buhling, S. Dermout, E. Lukkari-lax, and D. Apter, A phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescents. Contraception, Feb, p.001078241600036603, 2016.

P. Bednarek, M. Creinin, M. Reeves, C. Cwiak, E. Espey et al., Prophylactic Ibuprofen Does Not Improve Pain With IUD Insertion, Obstetrical & Gynecological Survey, vol.70, issue.4, 2015.
DOI : 10.1097/01.ogx.0000464935.96641.d9

L. Lopez, A. Bernholc, Y. Zeng, R. Allen, D. Bartz et al., Interventions for pain with intrauterine device insertion, Cochrane Database Syst Rev, vol.34, issue.12, p.3, 2015.
DOI : 10.1002/14651858.CD007373.pub3

A. Nelson, D. Apter, B. Hauck, T. Schmelter, S. Rybowski et al., Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems, Obstetrics & Gynecology, vol.122, issue.6, 2013.
DOI : 10.1097/AOG.0000000000000019

O. Heikinheimo, P. Inki, M. Kunz, and K. Gemzelle-danielsson, Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system, Human Reproduction, vol.25, issue.6
DOI : 10.1093/humrep/deq079

R. Salem, V. Setty, R. Williamson, and H. Schwandt, When contraceptives change monthly bleeding, Popul Rep J, vol.1, issue.54, pp.3-19, 2006.

P. Warner and J. Bancroft, Factors related to self-reporting of the pre-menstrual syndrome, The British Journal of Psychiatry, vol.157, issue.2, pp.249-60, 1990.
DOI : 10.1192/bjp.157.2.249

T. Backman, S. Huhtala, R. Luoto, J. Tuominem, I. Rauramo et al., Advance information improves user satisfaction with the levonorgestrel intrauterine system, Obstet Gynecol, vol.99, issue.4, pp.608-621, 2002.